A Study of Mental Health Care in People With Cancer

Study summary

The purpose of this study is to look at mental health services for adults with depressed mood who were diagnosed with cancer at the age of 65 or older. This study will compare the usual approach for connecting older adults with depressed mood to mental health services with the Open Door for Cancer (OD-C) approach. We will find out if the OD-C approach is practical and useful for cancer patients who participate in the intervention and for providers who see or treat cancer patients.

Ask AI to explain this study

Start here

Key things to know

Main goalOther

This describes the study’s primary purpose.

What is being studiedQuestionnaires and Interviews

Plus 1 other study approaches.

Who it may be forBreast Cancer · Colorectal Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Oct 5, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Memorial Sloan Kettering Cancer Center

Study sponsor

Study overview

What this study is about

Purpose: Other
Study type: Interventional
Phase: Not applicable
Sponsor: Memorial Sloan Kettering Cancer Center
Interventions being studied: Other: Questionnaires; Other: Interviews; Other: 30-minute telephone or videoconference sessions

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Patients
Per medical record and/or self-report, diagnosed with breast, colorectal, lung, or prostate cancer at age 65 years or older
Per medical record and/or self-report, undergoing active cancer treatment (e.g., radiation, chemotherapy, immunotherapy, surgery) or within six months of completing treatment
Score of ≥5 on the Patient Health Questionnaire-9 (PHQ-9)
Per self-report, fluent in English\*\
\*\
Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify English fluency necessary for participation in the study: 1. How well do you speak English? (must respond "very well" or "well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused) 2. What is your preferred language for healthcare? (must respond English) Providers
Per self-report, works in oncology, nursing, social work, psychology, or psychiatry
Per self-report, currently works in oncology at least 50% of the time
Per self-report, provided cancer care for at least three years at time of consent
Per self-report, fluent in English

Reasons someone may not be able to joinExclusion criteria

Patients
Severely cognitively impaired as demonstrated by Blessed Orientation Memory Concentration scores of ≥ 11
Per research staff judgment and/or self-report, too ill or weak to complete study procedures
Per medical record and/or self-report, receiving hospice care at the time of enrollment
Per medical record and/or self-report, currently enrolled in mental health treatment Providers
N/A

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Memorial Sloan Kettering Cancer CenterNew York, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 5, 2026. Always confirm current availability with the study team.

View original record ↗